Research Article
[Retracted] Propranolol Participates in the Treatment of Infantile Hemangioma by Inhibiting HUVECs Proliferation, Migration, Invasion, and Tube Formation
Figure 2
Propranolol inhibits HUVECs migration. By wound healing assay, the mobility of different concentrations (30, 60, 90, and 120 μM) of propranolol on HUVECs (a) and VEGF-induced HUVECs (b) was measured. (c) Quantitative mobility analysis. Magnification, 200x; vs. NC group; ## vs. VEGF group.
(a) |
(b) |
(c) |